Describe Massive Blood Transfusion & its Complications in detail.

Definition

Massive transfusion is replacement of the patient's entire blood volume within 24 hours (or > 10 units of red cells in 24 h, or > 4 units in an hour). It is life-saving in major haemorrhage — trauma, ruptured aneurysm, major surgery, obstetric bleeding — but rapidly infusing large volumes of stored blood creates predictable problems, and understanding why each arises is the key to preventing them.

Complications & Their Mechanisms

• Hypothermia — stored blood is cold; rapid infusion cools the patient, which itself impairs the clotting cascade and platelets. → warm all blood/fluids.
• Dilutional coagulopathy — stored red cells have few platelets/clotting factors, so replacing losses with red cells alone dilutes the patient's own clotting components.
• Hypocalcaemia — the citrate anticoagulant binds ionised calcium; large volumes drop calcium enough to impair clotting and cardiac function. → monitor/replace calcium.
• Hyperkalaemia — potassium leaks from stored red cells, so stored blood is potassium-rich.
• Acidosis — stored blood is acidic, adding to the acidosis of shock.

The Lethal Triad & Damage-control Resuscitation

Hypothermia, acidosis and coagulopathy reinforce one another as the feared 'lethal triad', making bleeding impossible to stop. Older practice gave red cells first and caught up with plasma/platelets later — reliably producing dilutional coagulopathy. Damage-control resuscitation reverses this: transfuse red cells, FFP and platelets together in a balanced (~1:1:1) ratio from the outset (reconstituting whole blood), apply permissive hypotension until surgical control, give tranexamic acid early (crash-2), keep the patient warm, and proceed to damage-control surgery. Above all, control the bleeding source — transfusion only buys time.

Monitoring

Monitor for the specific complications — temperature, ionised calcium, potassium, acid-base and clotting — increasingly guided by viscoelastic tests (TEG/ROTEM) that show in near-real-time which component is deficient, allowing targeted rather than blind replacement. Note that fibrinogen falls earliest in major haemorrhage and is replaced with cryoprecipitate/fibrinogen concentrate.

The Massive Transfusion Protocol & Evidence

Because massive haemorrhage is chaotic, hospitals use a pre-agreed massive transfusion protocol (MTP) activated with a single call, so the blood bank releases pre-defined packs of red cells, FFP and platelets in fixed ratios without waiting for individual requests. Two trials underpin practice: crash-2 showed early tranexamic acid reduces mortality in traumatic haemorrhage, and PROPPR supported the ~1:1:1 ratio.

Viscoelastic Testing (teg/rotem)

Conventional clotting tests are slow. Viscoelastic tests (TEG/ROTEM) analyse whole-blood clot formation, strength and breakdown at the bedside in near-real-time, showing which component is deficient — factors, fibrinogen, platelets or excess fibrinolysis — and so allow targeted, goal-directed replacement rather than blind fixed-ratio transfusion.

Control the Source, & the Role of Fibrinogen

Massive transfusion responds to massive haemorrhage — major trauma, ruptured aneurysm, upper GI or obstetric bleeding — and one principle sits above the transfusion itself: definitive control of the bleeding source by surgery or interventional radiology, because no volume of blood saves a patient who continues to bleed. Among the clotting components, fibrinogen falls earliest and most critically and strongly predicts continued bleeding, so modern protocols specifically replace it with cryoprecipitate or fibrinogen concentrate, often guided by viscoelastic testing — a frequently examined refinement of balanced resuscitation.

Warm the blood and replace calcium to avoid the lethal triad.

• Massive transfusion = ~1 blood volume in 24 h (or >10 units RBC).
• Complications: hypothermia, dilutional coagulopathy, hypocalcaemia (citrate binds Ca), hyperkalaemia, acidosis.
• Lethal triad = hypothermia + acidosis + coagulopathy, mutually reinforcing.
• Damage-control: balanced 1:1:1 from the start, permissive hypotension, early tranexamic acid, keep warm, control the source.
• Monitor temperature, ionised calcium, K⁺, acid-base, clotting (TEG/ROTEM); fibrinogen falls earliest.